GJA1 and glaucoma: Utilizing the advanced hfCas13X RNA editing system, we demonstrate that the targeted downregulation of Cx43 can effectively alleviate these pathogenic processes, thereby providing a novel therapeutic strategy to slow the progression of glaucoma.